Canada markets closed

COMPASS Pathways plc (CMPS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
8.38-0.04 (-0.48%)
At close: 04:00PM EDT
8.40 +0.02 (+0.24%)
After hours: 05:50PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close8.42
Open8.35
Bid8.32 x 100
Ask8.39 x 100
Day's Range8.23 - 8.70
52 Week Range5.01 - 12.75
Volume367,960
Avg. Volume714,407
Market Cap572.71M
Beta (5Y Monthly)2.48
PE Ratio (TTM)N/A
EPS (TTM)-2.32
Earnings DateMay 06, 2024 - May 10, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est41.25
  • GlobeNewswire

    Compass Pathways to participate in upcoming 23rd Annual Needham Virtual Healthcare Conference

    LONDON, April 01, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will present at the 23rd Annual Needham Virtual Healthcare Conference at 8:00am ET on April 9, 2024. A live audio webcast of the presentation will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible

  • Insider Monkey

    20 Most Depressed Countries in Asia

    In this article, we will be taking a look at the 20 most depressed countries in Asia. If you do not want to learn about the Asian depression market, head straight to the 5 Most Depressed Countries in Asia. Overview of the Global and Asian Depression Market The global depression market is a significant sector […]

  • GlobeNewswire

    Compass Pathways Board Chair and Co-Founder George Goldsmith and Co-Founder Ekaterina Malievskaia Step Down from Board of Directors

    David Norton Assumes Role of Interim Board Chair while the Company Runs a Global Search for a New ChairLONDON, March 28, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced that Board Chair and co-founder George Goldsmith and fellow co-founder Ekaterina Malievskaia have resigned their seats on the company’s board of directors, effective March 29, 2